Birgit Girshick Charles River Laboratories International, Inc. (CRL) insider trading activity

Birgit Girshick is Corporate Executive VP & COO of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 65,944 shares of CRL, which is worth approximately $9.96 Million. The most recent transaction as insider was on May 31, 2025, when has been sold 283 shares (Common Stock) at a price of $135.63 per share, resulting in proceeds of $38,383. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.9K

20.71% 3M change

30.55% 12M change

Total Value Held $9.96 Million

Birgit Girshick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2025	SELL Payment of exercise price or tax liability	$38,383 $135.63 p/Share	283 Reduced 0.43%	65,944 Common Stock
May 30 2025	BUY Grant, award, or other acquisition	$1,659,975 $135.63 p/Share	12,239 Added 15.6%	66,227 Common Stock
May 28 2025	SELL Payment of exercise price or tax liability	$16,222 $138.65 p/Share	117 Reduced 0.22%	53,988 Common Stock
May 27 2025	SELL Payment of exercise price or tax liability	$33,088 $136.73 p/Share	242 Reduced 0.45%	54,105 Common Stock
May 26 2025	SELL Payment of exercise price or tax liability	$38,421 $136.73 p/Share	281 Reduced 0.51%	54,347 Common Stock
Feb 25 2025	SELL Bona fide gift	-	430 Reduced 0.78%	54,628 Common Stock
Feb 20 2025	BUY Open market or private purchase	$249,249 $164.63 p/Share	1,514 Added 2.68%	55,058 Common Stock
Jan 31 2025	SELL Payment of exercise price or tax liability	$169,709 $165.57 p/Share	1,025 Reduced 1.88%	53,544 Common Stock
Jan 31 2025	BUY Grant, award, or other acquisition	-	4,057 Added 6.92%	54,569 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	3,838 Added 7.06%	50,512 Common Stock
May 29 2024	SELL Payment of exercise price or tax liability	$46,334 $214.51 p/Share	216 Reduced 0.46%	46,674 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$28,671 $217.21 p/Share	132 Reduced 0.28%	46,890 Common Stock
May 27 2024	SELL Payment of exercise price or tax liability	$52,564 $217.21 p/Share	242 Reduced 0.51%	47,022 Common Stock
May 26 2024	SELL Payment of exercise price or tax liability	$81,670 $217.21 p/Share	376 Reduced 0.79%	47,264 Common Stock
Feb 15 2024	SELL Bona fide gift	-	424 Reduced 0.88%	47,691 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$255,304 $220.28 p/Share	1,159 Reduced 2.35%	48,115 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	3,526 Added 6.68%	49,274 Common Stock
Jan 10 2024	SELL Payment of exercise price or tax liability	$987,722 $215.19 p/Share	4,590 Reduced 9.11%	45,775 Common Stock
Jan 10 2024	BUY Exercise of conversion of derivative security	$1,273,064 $215.19 p/Share	5,916 Added 10.51%	50,365 Common Stock
Nov 20 2023	BUY Open market or private purchase	$248,298 $187.82 p/Share	1,322 Added 2.89%	44,449 Common Stock
May 29 2023	SELL Payment of exercise price or tax liability	$41,929 $194.12 p/Share	216 Reduced 0.49%	43,477 Common Stock
May 28 2023	SELL Payment of exercise price or tax liability	$25,623 $194.12 p/Share	132 Reduced 0.3%	43,693 Common Stock
May 27 2023	SELL Payment of exercise price or tax liability	$46,977 $194.12 p/Share	242 Reduced 0.55%	43,825 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	3,812 Added 7.96%	44,067 Common Stock
Mar 07 2023	SELL Bona fide gift	-	475 Reduced 1.17%	40,255 Common Stock

Birgit Girshick

Corporate Executive VP & COO

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account